Back to full portfolio

Adimab

WEBSITE
LEADERSHIP
Tillman Gerngross
Market-leading antibody drug discovery platform.
SECTOR(S)
Healthcare
INVEStMENT STAGE
Growth
STATUS
Private

More about Adimab

No items found.